Differentially expressed genes from the glioblastoma cell line SHG-44 treated with all-trans retinoic acid in vitro

Journal of Clinical Neuroscience

Volumn 16, Issue 2, 2009, Pages 285-294

  Zeng, Yi ^a   Yang, Zhong ^b   Xu, Jian Guo ^a   Yang, Meng Su ^c   Zeng, Zhi Xiong ^c   You, Chao ^a  

^a SICHUAN UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Astrocytoma; cDNA microarray; Differentiation; Proliferation; Retinoic acid (RA); SHG 44

Indexed keywords

RETINOIC ACID;

ARTICLE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NORTHERN BLOTTING; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOBLASTOMA; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRETINOIN;

EID: 58149187853     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.11.014     Document Type: Article

References (30)

1. Kleihues P., Davis R.L., Ohgaki H., et al. Diffuse astrocytoma. In: Kleihues P., and Cavenee W.K. (Eds). Pathology and genetics of tumors of the Nervous System (2000), IARC Press, Lyon, France 22-26
2. Kleihues P., Louis D.N., Scheithauer B.W., et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61 (2002) 215-225
3. Grummer M.A., Salih Z.N., and Zachman R.D. Effect of retinoic acid and ethanol on retinoic acid receptor beta and glial fibrillary acidic protein mRNA expression in human astrocytoma cells. Neurosci Lett 294 (2000) 73-76
4. Kim E.J., Kang Y.H., Schaffer B.S., et al. Inhibition of Caco-2 cell proliferation by all-trans retinoic acid: role of insulin-like growth factor binding protein-6. J Cell Physiol 190 (2002) 92-100
5. Du Z.W. Establishment of human malignant glioma cell line (SHG-44) and observation on its characteristics. Zhonghua Zhong Liu Za Zhi 6 (1984) 241-243
6. Bouterfa H., Picht T., Kess D., et al. Retinoids inhibit human glioma cell proliferation and migration in primary cell cultures but not in established cell lines. Neurosurgery 46 (2000) 419-430
7. Kohleisen B., Hutzler P., Shumay E., et al. HIV-1 Nef co-localizes with the astrocyte-specific cytoskeleton protein GFAP in persistently nef-expressing human astrocytes. J Neurovirol 7 (2001) 52-55
8. Hunter S., Young A., Olson J., et al. Differential expression between pilocytic and anaplastic astrocytomas: identification of apolipoprotein D as a marker for low-grade, non-infiltrating primary CNS neoplasms. J Neuropathol Exp Neurol 61 (2002) 275-281
9. Balint E.E., and Vousden K.H. Activation and activities of the p53 tumor suppressor protein. Br J Cancer 85 (2001) 1813-1823
10. Momand J., Wu H.H., and Dasgupta G. MDM2-master regulator of the p53 tumor suppressor protein. Gene 242 (2000) 15-29
11. Alkhalaf M., Ganguli G., Messaddeq N., et al. MDM2 overexpression generates a skin phenotype in both wild type and p53 null mice. Oncogene 18 (1999) 1419-1434
12. Grier J.D., Xiong S., Elizondo-Fraire A.C., et al. Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4. Mol Cell Biol 26 (2006) 192-198
13. Barbieri E., Mehta P., Chen Z., et al. MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death. Mol Cancer Ther 5 (2006) 2358-2365
14. Li M., Zhang Z., Hill D.L., et al. Genistein, a dietary isoflavone, down-regulates the MDM2 oncogene at both transcriptional and posttranslational levels. Cancer Res 65 (2005) 8200-8208
15. Tews D.S. Cell death and oxidative stress in gliomas. Neuropathol Appl Neurobiol 25 (1999) 272-284
16. Cullen J.J., Weydert C., Hinkhouse M.M., et al. The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. Cancer Res 63 (2003) 1297-1303
17. Hurt E.M., Thomas S.B., Peng B., et al. Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines. Br J Cancer 97 (2007) 1116-1123
18. Hodge D.R., Xiao W., Peng B., et al. Enforced expression of superoxide dismutase 2/manganese superoxide dismutase disrupts autocrine interleukin-6 stimulation in human multiple myeloma cells and enhances dexamethasone-induced apoptosis. Cancer Res 65 (2005) 6255-6263
19. Drane P., Bravard A., Bouvard V., et al. Reciprocal down-regulation of p53 and SOD2 gene expression-implication I p53 mediated apoptosis. Oncogene 20 (2001) 430-439
20. Keppler D. Towards novel anti-cancer strategies based on cystatin function. Cancer Lett 235 (2006) 159-176
21. Di Piazza M., Mader C., Geletneky K., et al. Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells. J Virol 81 (2007) 4186-4198
22. Zhang R., Tremblay T.L., McDermid A., et al. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors. Glia 42 (2003) 194-208
23. Peri A., Bonaccorsi L., Muratori M., et al. Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC-1A by disrupting the metabolic pathways generating platelet-activating factor. Int J Cancer 88 (2000) 525-534
24. Lee J.C., Park K.H., Han S.J., et al. Inhibitory effect of adenovirus-uteroglobin transduction on the growth of lung cancer cell lines. Cancer Gene Ther 10 (2003) 287-293
25. Fleming T.P., and Watson M.A. Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer. Ann N Y Acad Sci 923 (2000) 78-89
26. Tourriere H., Chebli K., Zekri L., et al. The RasGAP-associated endoribonuclease G3BP assembles stress granules. J Cell Biol 160 (2003) 823-831
27. Barnes C.J., Li F., Mandal M., et al. Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors. Cancer Res 62 (2002) 1251-1255
28. Irvine K., Stirling R., Hume D., et al. Rasputin, more promiscuous than ever: a review of G3BP. Int J Dev Biol 48 (2004) 1065-1077
29. Kim M.M., Wiederschain D., Kennedy D., et al. Modulation of p53 and MDM2 activity by novel interaction with Ras-GAP binding proteins (G3BP). Oncogene 26 (2007) 4209-4215
30. Liu Y., Zheng J., Fang W., et al. Identification of metastasis associated gene G3BP by differential display in human cancer cell sublines with different metastatic potentials G3BP as highly expressed in non-metastatic. Chin Med J 114 (2001) 35-38